Alopecia areata was more likely to develop in patients with inflammatory bowel disease (IBD) who were taking anti–tumor necrosis factor (TNF) therapy at the onset of the condition.
Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition that affects around ...
The disease causes perifollicular erythema, pustules, crusting, and oozing. Small areas of scarring alopecia gradually appear and may become extensive and impressive, leaving large areas of bare ...
Following after are etrasimod studies in Crohn's disease, eosinophilic oesophagitis, alopecia areata and atopic dermatitis, which if positive could dramatically increase the drug's potential.